Exagen (NASDAQ:XGN) is preparing to release its quarterly earnings on Tuesday, 2026-03-10. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Exagen to report an earnings per share (EPS) of $-0.20.
The market awaits Exagen's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
Last quarter the company missed EPS by $0.04, which was followed by a 4.09% drop in the share price the next day.
Here's a look at Exagen's past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.15 | -0.16 | -0.21 | -0.24 |
| EPS Actual | -0.19 | -0.18 | -0.20 | -0.20 |
| Price Change % | -4.09 | 2.13 | 2.72 | -1.19 |
Market Performance of Exagen's Stock
Shares of Exagen were trading at $3.29 as of March 06. Over the last 52-week period, shares are down 1.19%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for Exagen visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment